TyraTech
<< < > >>
Search:
 
| Full PDF report | Print this page |
Annual Report & Accounts 2010 - Chairman's Statement and Operational Review
slide
<< < > >>
Also in February 2011, Keith Kennedy, Ph.D. joined TyraTech as Vice President of Product Development. Dr. Kennedy has more than 22 years of experience in the development of global consumer products. As Director of S.C. Johnson and Son's (SCJ) Insect Control Product Development Division, he led global development teams that successfully introduced over 75 new chemical specialty products worldwide, products that are now being sold in over 100 countries. Dr. Kennedy's key product responsibilities at SCJ included: Raid® and Baygon® insecticides; Off!® and Autan® insect repellents. Before moving into product development, Dr. Kennedy directed the efforts of SCJ's Entomology Research Center. For the last five years, Dr. Kennedy has worked as a private consultant for new insect control and repellent technology. Other Business : As I write this report to you, we are in the process of relocating TyraTech's operations to the Research Triangle Park (RTP) area of North Carolina. We are making this move in order for the business to be located in a hub with other Life Science businesses. We believe this will provide TyraTech with greater access to a talented employment base and other scientific expertise through the vast network of public and private research facilities in the RTP area. I am also pleased with the continued development of TyraChem, our innovative Joint Venture with Chemplast International (Chemplast). As part of McNeel International Corporation, Chemplast is a multinational plastics and master batch manufacturer. In 2011, the companies continue working together to develop innovative technology platforms that leverage TyraTech's Nature's Technology™ insecticide platform into novel delivery systems. Summary and Outloo k: We continue to be confident of TyraTech's technology and of our ability to develop further products that our partners can commercialise, as evidenced by the new products we have delivered to Terminix. We are also committed to leveraging these products into other markets and to create significant shareholder value over the coming years. While there is much work left to be done, we are proud of the accomplishments we achieved in 2010 and look forward to similar accomplishments in 2011 and beyond. Alan Reade, Executive Chairman 20 June 2011 08